These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26091275)

  • 1. Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.
    Saraceno R; Lorè B; Pavlidis A; Karaiskou M; Arcuri C; Chimenti S; Magnato R
    G Ital Dermatol Venereol; 2016 Oct; 151(5):480-4. PubMed ID: 26091275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture and burning mouth syndrome: a pilot study.
    Sardella A; Lodi G; Tarozzi M; Varoni E; Franchini R; Carrassi A
    Pain Pract; 2013 Nov; 13(8):627-32. PubMed ID: 23336607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.
    Amos K; Yeoh SC; Farah CS
    J Orofac Pain; 2011; 25(2):125-30. PubMed ID: 21528119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised.
    Cano-Carrillo P; Pons-Fuster A; López-Jornet P
    J Oral Rehabil; 2014 Apr; 41(4):296-305. PubMed ID: 24612248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study.
    Rodríguez de Rivera Campillo E; López-López J; Chimenos-Küstner E
    Bull Group Int Rech Sci Stomatol Odontol; 2010 May; 49(1):19-29. PubMed ID: 22750263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    Mitsikostas DD; Ljubisavljevic S; Deligianni CI
    J Headache Pain; 2017 Dec; 18(1):40. PubMed ID: 28357703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study.
    Barry A; O'Halloran KD; McKenna JP; McCreary C; Downer EJ
    J Oral Pathol Med; 2018 Feb; 47(2):158-165. PubMed ID: 29194773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial.
    Valenzuela S; Pons-Fuster A; López-Jornet P
    J Oral Pathol Med; 2016 Aug; 45(7):528-33. PubMed ID: 26694632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome.
    López-Jornet P; Camacho-Alonso F; Molino-Pagan D
    J Oral Pathol Med; 2013 Apr; 42(4):295-301. PubMed ID: 22957483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
    Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
    Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome.
    Jørgensen MR; Pedersen AM
    Acta Odontol Scand; 2017 Mar; 75(2):130-136. PubMed ID: 28007005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study.
    Petruzzi M; Lauritano D; De Benedittis M; Baldoni M; Serpico R
    J Oral Pathol Med; 2004 Feb; 33(2):111-4. PubMed ID: 14720197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study.
    Pekiner FN; Gumru B; Ozbayrak S
    J Orofac Pain; 2008; 22(2):146-52. PubMed ID: 18548844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-level laser therapy in the treatment of burning mouth syndrome: a case series.
    dos Santos Lde F; Carvalho Ade A; Leão JC; Cruz Perez DE; Castro JF
    Photomed Laser Surg; 2011 Dec; 29(12):793-6. PubMed ID: 22150094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome predictors of initial treatment with topical lubricant and parafunctional habit control in burning mouth syndrome (BMS).
    Ko JY; Park IH; Park HK; Kho HS
    Arch Gerontol Geriatr; 2011; 53(3):263-9. PubMed ID: 21075463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative effect of lafutidine on oral burning sensation.
    Toida M; Kato K; Makita H; Long NK; Takeda T; Hatakeyama D; Yamashita T; Shibata T
    J Oral Pathol Med; 2009 Mar; 38(3):262-8. PubMed ID: 19175712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of levosulpiride in burning mouth syndrome.
    Demarosi F; Tarozzi M; Lodi G; Canegallo L; Rimondini L; Sardella A
    Minerva Stomatol; 2007; 56(1-2):21-6. PubMed ID: 17287703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.